View in EDS

Therapeutic Lymphangiogenesis Using Induced Cardiac Fibroblasts Protects the Heart From Heart Failure With Preserved Ejection Fraction Progression by Exerting Anti-Inflammatory and Antifibrotic Effects.

Saved in:

Bibliographic Details
Title:	Therapeutic Lymphangiogenesis Using Induced Cardiac Fibroblasts Protects the Heart From Heart Failure With Preserved Ejection Fraction Progression by Exerting Anti-Inflammatory and Antifibrotic Effects.
Authors:	Luo H; Department of Cardiology, Nagoya University Graduate School of Medicine., Shimizu Y; Department of Cardiology, Nagoya University Graduate School of Medicine., Iwamiya T; Research & Development Department, LYMPHOGENiX Ltd., Matsuoka Y; Department of Cardiology, Nagoya University Graduate School of Medicine.; Research & Development Department, LYMPHOGENiX Ltd., Chen X; Department of Cardiology, Nagoya University Graduate School of Medicine., Liu T; Department of Cardiology, Nagoya University Graduate School of Medicine., Che Y; Department of Cardiology, Nagoya University Graduate School of Medicine., Hayashi T; Department of Cardiology, Nagoya University Graduate School of Medicine., Pu Z; Department of Cardiology, Nagoya University Graduate School of Medicine., Yamaguchi S; Department of Cardiology, Nagoya University Graduate School of Medicine., Sakamoto K; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine., Murohara T; Department of Cardiology, Nagoya University Graduate School of Medicine.
Source:	Circulation journal : official journal of the Japanese Circulation Society [Circ J] 2026 May 25; Vol. 90 (6), pp. 616-627. Date of Electronic Publication: 2026 Jan 28.
Publication Type:	Journal Article
Journal Info:	Publisher: Japanese Circulation Society Country of Publication: Japan NLM ID: 101137683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1347-4820 (Electronic) Linking ISSN: 13469843 NLM ISO Abbreviation: Circ J Subsets: MEDLINE
Database:	MEDLINE Ultimate

Be the first to leave a comment!